Latest Euronext Brussels News


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

12/17/2017 08:17 AM


EMA's CHMP recommends five new drugs at its December 2017 meeting
The Pharma Letter
The CHMP recommended granting a marketing authorization for the ATMP Alofisel (darvadstrocel), from Takeda Pharmaceutical (TYO: 4502) and TiGenix (Euronext Brussels: TIG), for the treatment of complex perianal fistulas in patients with Crohn's disease ...

and more »

12/16/2017 12:33 PM


Bone Therapeutics SA : Provides Update on Equity Placement
GlobeNewswire (press release)
Gosselies, Belgium, 15 December 2017, 4:45 pm CET - Bone Therapeutics (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases (the "Company"), announces that it has ...

and more »

12/15/2017 03:46 PM


Business Wire (press release)

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex ...
Business Wire (press release)
OSAKA, Japan & LEUVEN, Belgium--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP ...

12/15/2017 12:34 PM


Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the ...
GlobeNewswire (press release)
NEW YORK and MELBOURNE, Australia and LEUVEN, Belgium, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) and TiGenix NV (Euronext Brussels:TIG) (Nasdaq:TIG) today announce that Mesoblast has granted TiGenix exclusive access to ...

and more »

12/15/2017 12:34 AM


Bone Therapeutics SA Launches Equity Placement
GlobeNewswire (press release)
Trading in the Company's shares on Euronext Brussels and Euronext Paris will be suspended during the book building period and trading in the stock is expected to resume following the publication of the results of the Offering. Bryan, Garnier & Co is ...

and more »

12/14/2017 01:02 PM